Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
about
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.Planning interventional trials in childhood arterial ischaemic stroke using a Delphi consensus process.Corticosteroids in the management of acute multiple sclerosis exacerbations.
P2860
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@ast
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@en
type
label
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@ast
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@en
prefLabel
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@ast
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@en
P2860
P1433
P1476
Quantitative benefit-risk asse ...... n multiple sclerosis relapses.
@en
P2093
I Ralph Edwards
Ola Caster
P2860
P2888
P356
10.1186/S12883-015-0450-X
P577
2015-10-16T00:00:00Z
P5875
P6179
1000987494